Jenburkt Pharmaceuticals Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Cash & Equivalents	531.15	73.65	41.25	36.6	50.31
Short-Term Investments	-	157.79	698.44	458.25	415.55
Cash & Short-Term Investments	531.15	231.43	739.69	494.84	465.86
Cash Growth	129.50%	-68.71%	49.48%	6.22%	-10.42%
Accounts Receivable	243.57	207.35	194.75	169.62	152.07
Other Receivables	1.58	11	50.02	42.28	21.31
Receivables	245.78	218.87	245.67	213.08	175.28
Inventory	136.33	88.8	85.66	83.38	98.98
Prepaid Expenses	-	11.59	6.77	4.59	5.53
Other Current Assets	37.63	14.61	19.49	15.02	13.39
Total Current Assets	950.89	565.32	1,097	810.91	759.04
Property, Plant & Equipment	653.4	547.06	112.14	112.19	113.05
Long-Term Investments	270.24	767.44	173.9	344.09	415.71
Other Intangible Assets	2.41	2.28	3.88	1.87	3.06
Long-Term Deferred Tax Assets	23.99	14.69	7.98	4.25	3.71
Other Long-Term Assets	359.13	64.89	255.51	144.23	133.59
Total Assets	2,260	1,962	1,651	1,418	1,429
Accounts Payable	81	81.55	62.57	60.97	71.1
Accrued Expenses	-	16.04	9.31	2.55	2.59
Short-Term Debt	-	19.79	-	24.39	58.15
Current Portion of Leases	6.49	4.23	-	4.89	4.51
Current Income Taxes Payable	11.38	2.86	16.41	3.37	0.77
Other Current Liabilities	132.61	63.72	75.49	61.46	75.67
Total Current Liabilities	231.47	188.19	163.79	157.62	212.8
Long-Term Leases	18.4	14.92	-	-	4.89
Long-Term Deferred Tax Liabilities	9.76	10.87	7.9	7.18	8.56
Other Long-Term Liabilities	30.1	30.1	29.91	29.43	29.43
Total Liabilities	289.72	244.09	201.59	194.22	255.67
Common Stock	44.13	44.13	44.13	44.13	45.89
Retained Earnings	-	1,657	1,375	1,165	1,119
Comprehensive Income & Other	1,926	16.76	30.62	15.25	9.2
Shareholders' Equity	1,970	1,718	1,449	1,224	1,174
Total Liabilities & Equity	2,260	1,962	1,651	1,418	1,429
Total Debt	24.88	38.94	-	29.28	67.55
Net Cash (Debt)	506.26	192.5	739.69	465.57	398.31
Net Cash Growth	163.00%	-73.98%	58.88%	16.89%	-15.15%
Net Cash Per Share	114.72	43.62	167.61	101.97	86.79
Filing Date Shares Outstanding	4.41	4.41	4.41	4.41	4.59
Total Common Shares Outstanding	4.41	4.41	4.41	4.41	4.59
Working Capital	719.43	377.12	933.49	653.29	546.24
Book Value Per Share	446.40	389.23	328.42	277.32	255.77
Tangible Book Value	1,968	1,715	1,446	1,222	1,171
Tangible Book Value Per Share	445.86	388.71	327.54	276.90	255.10
Buildings	-	117.96	107.24	103.86	101.39
Machinery	-	237.32	206.45	193.64	191.2
Construction In Progress	-	402.77	12.41	9.57	2.12

Source: S&P Global Market Intelligence. Standard template. Financial Sources.